Researchers say they’re one step closer to being able to diagnose Alzheimer's disease using a finger prick blood test. The test has the potential to be used at home and reach more people, they said.

A quick finger prick and a few drops of blood on a card that can be sent in regular mail—This approach could soon make Alzheimer's testing much more accessible worldwide. A European study led by ...

This is where the new finger prick blood test could be beneficial, according to Maria C. Carrillo, PhD, chief science officer of the Alzheimer’s Association, who is based in Chicago, Illinois.

Once the test is perfected, doctors in rural areas or at smaller hospitals -- or even average folks -- could take a finger prick blood sample and ship it off to a facility equipped with the highly ...

Sight Diagnostics believes it can succeed where Theranos failed, developing rapid finger-prick blood tests, but its approach is nothing like that of the failed Silicon Valley startup chronicled in ...

The dream of Theranos for finger-prick blood tests is now a reality, thanks to the efforts of rival companies. In Austin, Texas, people who fear needles can now undergo routine medical tests using ...

Palo Alto-based Theranos is revolutionizing the traditional blood test by eliminating the lab, and providing technology that uses a finger prick similar to blood tests diabetics use to measure ...

Alzheimer's Association International Conference (AAIC) 2023: Abstract 80275 (finger-prick blood test); Abstract 78819 (primary care). Both were presented July 19, 2023.

A finger-prick blood test in Austin, Texas. By Peter Loftus | Photographs by Sergio Flores for WSJ . July 30, 2024 5:30 am ET. Listen to article (2 minutes) ...

An Austin, Texas-based company is bringing a new type of “finger prick” blood tests to pharmacies that they say is quicker and more convenient than standard tests. Skip to main content.

A quick finger prick and a few drops of blood on a card that can be sent in regular mail. This approach could soon make Alzheimer's testing much more accessible worldwide.